The Pregnatal Diagnosis Center, Jinan Maternity and Child Care Hospital, Jinan, Shandong, China.
Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5527-5533. doi: 10.26355/eurrev_201712_13988.
Endometriosis is a disease that occurs in women. Thrombin-activated fibrinolytic inhibitor (TAFI) is mainly secreted by stem cells and acts as a regulatory role in the body. Epithelial leaf transition plays a leading role in cell growth and invasion. Our study focuses on the mechanism of TAFI in patients with endometriosis.
The expression of TAFI was determined by immunohistochemistry. Reverse transcriptase-polymerase chain reaction (RT-PCR) served to detect the expression of TAFI and the effect of TAFI on overall survival (OS) and progression-free survival (PFS) levels. The changes of primary cytology in patients with endometriosis were observed under a microscope. The cell source was further determined by immunofluorescence labeling of vimentin and cytokeratin, and the expression of TAFI was detected by Western-blot. 3-4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and cell invasion assay were utilized to detect the viability and aggressiveness of cells after epithelial mesenchymal transition (EMT).
TAFI was overexpressed in endometriosis tissues and no expression of TAFI was found in normal tissues, which is consistent with RT-PCR results. TAFI overexpressed endometriosis patients had low levels of overall OS and PFS. There were statistically significant differences. Cell morphology shows that endometriosis primary cells are mainly composed of epithelial cells and fibroblasts. Immunofluorescence assay showed that vimentin and cytokeratin were expressed in cells, and the expression of TAFI was detected by Western-blot. Compared with normal tissues, TAFI was considerably higher in patients with endometriosis. The results of Western-blot and RT-PCR showed that the expression of TAFI was significantly increased in patients with endometriosis and the cell proliferation and cell invasion were significantly accelerated.
Our results show that TAFI is highly expressed in endometriosis and causes EMT, which accelerated the cell proliferation and cell invasion. Snail is an inhibitor of E-cadherin, which may participate in metastasis and invasion of endometriosis by mediating EMT. So, we suspect that Snail controls the occurrence of the EMT and then affects the cell metastasis and invasion, which requires further verification.
子宫内膜异位症是一种发生在女性身上的疾病。凝血酶激活的纤溶抑制物(TAFI)主要由干细胞分泌,在体内发挥调节作用。上皮叶过渡在细胞生长和侵袭中起主导作用。我们的研究重点是 TAFI 在子宫内膜异位症患者中的作用机制。
通过免疫组织化学测定 TAFI 的表达。逆转录-聚合酶链反应(RT-PCR)用于检测 TAFI 的表达以及 TAFI 对总生存期(OS)和无进展生存期(PFS)水平的影响。在显微镜下观察子宫内膜异位症患者的原代细胞学变化。通过波形蛋白和细胞角蛋白的免疫荧光标记进一步确定细胞来源,并通过 Western-blot 检测 TAFI 的表达。3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)和细胞侵袭实验用于检测上皮间质转化(EMT)后细胞的活力和侵袭性。
TAFI 在子宫内膜异位症组织中过度表达,而在正常组织中无表达,这与 RT-PCR 结果一致。TAFI 过度表达的子宫内膜异位症患者的总 OS 和 PFS 水平较低。存在统计学显著差异。细胞形态学显示,子宫内膜异位症原代细胞主要由上皮细胞和成纤维细胞组成。免疫荧光检测显示细胞中表达波形蛋白和细胞角蛋白,并通过 Western-blot 检测 TAFI 的表达。与正常组织相比,子宫内膜异位症患者的 TAFI 表达明显升高。Western-blot 和 RT-PCR 的结果表明,子宫内膜异位症患者的 TAFI 表达明显增加,细胞增殖和细胞侵袭明显加快。
我们的结果表明,TAFI 在子宫内膜异位症中高表达,并导致 EMT,从而加速细胞增殖和细胞侵袭。Snail 是 E-钙黏蛋白的抑制剂,可能通过介导 EMT 参与子宫内膜异位症的转移和侵袭。因此,我们怀疑 Snail 控制 EMT 的发生,进而影响细胞转移和侵袭,这需要进一步验证。